Title |
Patient-centered outcomes and trials of hydroxyethyl starch
|
---|---|
Published in |
Critical Care, September 2013
|
DOI | 10.1186/cc13023 |
Pubmed ID | |
Authors |
John Myburgh, Simon Finfer, Rinaldo Bellomo |
Abstract |
Meybohm and colleagues propose that hydroxyethyl starch (HES) may be used safely in hypovolemic patients by applying a clinical algorithm and by restricting the dose administered. |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 10% |
Unknown | 9 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 30% |
Professor | 1 | 10% |
Student > Master | 1 | 10% |
Student > Ph. D. Student | 1 | 10% |
Professor > Associate Professor | 1 | 10% |
Other | 1 | 10% |
Unknown | 2 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 60% |
Social Sciences | 1 | 10% |
Unknown | 3 | 30% |